Editorial Board Member
Laboratory of Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Investigation of Salamanca (IBSAL), Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; National Center for the Study of Liver and Digestive Diseases (CIBEREHD), Carlos III National Institute of Health, Madrid, Spain.
HomePage
Research Interests
liver cancer, chemoresistance characterization and sensitization, drug targeting, gene therapy strategies
Contributions: